Page last updated: 2024-09-05

sb 203580 and Signet Ring Cell Carcinoma

sb 203580 has been researched along with Signet Ring Cell Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukui, Y; Ihara, S; Karouji, Y; Kobayashi, M; Konishi, H; Xu, Q1

Other Studies

1 other study(ies) available for sb 203580 and Signet Ring Cell Carcinoma

ArticleYear
The PI 3-kinase-Rac-p38 MAP kinase pathway is involved in the formation of signet-ring cell carcinoma.
    Oncogene, 2003, Aug-28, Volume: 22, Issue:36

    Topics: Adenocarcinoma; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Signet Ring Cell; Cell Communication; Cell Differentiation; Chromones; Humans; Imidazoles; MAP Kinase Kinase 3; MAP Kinase Kinase 6; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Morpholines; Mucin-1; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Protein-Tyrosine Kinases; Pyridines; rac GTP-Binding Proteins

2003